Role of Glycopeptides in the Treatment of Septic Complications after Cardiac Surgery

References

• Watanakunakorn C. Prosthetic valve infective endocardi-tis. Prog Cardiovasc Dis 1979; 22: 181–192.
   PubMed Web of Science ®Google Scholar
• Calderwood S, Swinski L, Waternaux C. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985; 72: 31–37.
   PubMed Web of Science ®Google Scholar
• Karchmer AW, Gibbons GW. Infections of prosthetic heart valves and vascular grefts. In: Bisno AL, Waldvogel FA, eds. Infections associated with indwelling medical devices. Washington: ASM Press, 1994: 213–249.
   Google Scholar
• Wilson WR, Dianelson GK, Guiliani ER, Geraci JE. Prosthetic valve endocarditis. Mayo Clin Proc 1982; 57: 155–161.
   PubMed Web of Science ®Google Scholar
• Braimbridge MV, Eykyn SJ. Prosthetic valve endocardi-tis. J Antimicrob Chemother 1987; 20: 173–180.
   PubMed Web of Science ®Google Scholar
• Rossiter SJ, Stinson EB, Oyer PE. Prosthetic valve endocarditis: comparison of heterograft tissue valves and mechanical valves. J Thorac Cardiovasc Surg 1978; 76: 795–803.
   PubMed Web of Science ®Google Scholar
• Masur H. Prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1980; 80: 31–37.
   PubMed Web of Science ®Google Scholar
• Wilson WR, Jaumin; Danielson G, et al. Prosthetic valve endocarditis. Ann Intern Med 1975; 82: 751–759.
   PubMed Web of Science ®Google Scholar
• Sande MA, Shield WM. Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med 1980; 92: 390–401.
   PubMed Web of Science ®Google Scholar
• Karchmer AW. Staphylococcus epidermidis prosthetic valve endocarditis: microbiological and clinical observations as guides to therapy. Ann Intern Med 1983; 98: 447–452.
   PubMed Web of Science ®Google Scholar
• James JK, Palmer DP, Levine DP, Rybak MJ. Comparison of conventional dosing versus continuous infusion vancomycin therapy for patients with suspected or document-ed Gram positive infections. Antimicrob Agents Chemother 1996; 40: 696–700.
   PubMed Web of Science ®Google Scholar
• Moellering RC. Pharmacokinetics of vancomycin. J Antimicrob Chemother 1984; 14 (Suppl D): 43-52.
   Google Scholar
• Albanèse J, Bruguerolles B, Thomachot L, Vialet R, Potié F, Martin C. Etude pharmacocinétique de la van-comycine en perfusion continue dans le serum et le LCR chez des patients sous ventilation mécanique. Ann Fr Anesth Réanim 1996; 15: R351 [abstract].
   Google Scholar
• Carver PL, Nightingale CH, Quintillani R, Sweeney K, Stevens RC, Maderazo E. Pharmacokinetics of single- and multiple dose of teicoplanin in healthy volunteers. Antimicrob Agents Chemother 1989; 33: 82–86.
   PubMed Web of Science ®Google Scholar
• Antony KK, Lewis EW, Kenny MT, et al. Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administra-tion to humans. J Pharm Sci 1991; 80: 605–607.
   PubMed Web of Science ®Google Scholar
• Del Favero A, Patoia L, Rosina (AUTHOR, INI-TIAL???), et al. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses. Antimicrob Agents Chemother 1991; 35: 2551–2557.
   PubMed Web of Science ®Google Scholar
• Brogden RN, Peters DH. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and ther-apeutic efficacy. Drugs 1994; 47: 823–854.
   Google Scholar
• Assandri A, Bernareggi A. Binding of teicoplanin to human serum albumin. Eur J Clin Pharmacol 1987; 33: 191–195.
   PubMed Web of Science ®Google Scholar
• Derbyshire N, Webb DB, Roberts D, Glew D, Williams JD. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function. J Antimicrob Chemother 1989; 23: 869–876.
   PubMed Web of Science ®Google Scholar
• Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Eng J Med 1987; 316: 927–931.
   PubMed Web of Science ®Google Scholar
• Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 1990; 28: 2064–2068.
   PubMed Web of Science ®Google Scholar
• May J,y Shannon K, King A, French G. Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 189–197.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Artaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–1673.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med 1998; 104 (Suppl 5A): 7S-10S.
   Google Scholar
• Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to van-comycin-United States. MMWR Morb Mortal Wkly Rep 1997; 46: 626–635.
   PubMedGoogle Scholar
• Recommendations for preventing the spread of van-comycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995; 44 (RR-12): 1-13.
   Google Scholar
• Turco TF, Melko GP, Williams JR. Vancomycin inter-mediate-resistant Staphylococcus aureus. Ann Pharmacother 1998; 32: 758–760.
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520–532.
   PubMed Web of Science ®Google Scholar
• Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493–501.
   PubMed Web of Science ®Google Scholar
• Waldvogel FA. New resistance in Staphylococcus aureus infection. N Engl J Med 1999; 340: 556–557.
   PubMed Web of Science ®Google Scholar
• Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiratmatsu H. Actived cell-wall synthesis is associated with vancomycin resistance in methcillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 1998; 42: 199–209.
   PubMed Web of Science ®Google Scholar
• Moreira B, Boyle-Vavra S, de Jonge BLM, Daum RS. Increased production of penicillin binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1997; 41: 1788–1793.
   PubMed Web of Science ®Google Scholar
• Wysocki M, Thomas F, Wolff M, Pean Y, Ravaud Y, Herman B. Comparison of continuous with discontinuous infu-sion of vancomycin in severe MRSA infections. J Antimicrob Chemother 1995; 35: 352–354.
   PubMed Web of Science ®Google Scholar
• Wysocki M, Rauss A, Pean Y, et al. Continuous infu-sion of vancomycin for severe methicillin-resistant staphylococ-cal infections. Intensive Care Med 1996; 22: S325.
   Google Scholar
• Straubaugh L, Murray TW, Sande MA. Comparative penetration of 6 antibiotics into the cerebrospinal fluid of rab-bits with experimental staphylococcal meningitis. J Antimicrob Chemother 1980; 6: 363–371.
   PubMed Web of Science ®Google Scholar
• Albanèse J, Léone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 2000; 44: 1356–1358.
   PubMed Web of Science ®Google Scholar
• Kobasa WD, Kaye KL, Shapiro T. Therapy of experi-mental Staphylococcus epidermidis endocarditis. Rev Infect Dis 1983; 5 (suppl 3- S533).
   Google Scholar
• Karchmer AW, Archer GA. Endocarditis study group. Methicillin-resistant Staphylococcus epidermidis prosthetic valve endocarditis: A therapeutic trial. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1984: (abstract 476).
   Google Scholar
• Lytle BW. Surgical treatment of prosthetic valve endo-carditis. Semin Thorac Cardiovasc Surg 1995; 7 (1): 13–19.
   PubMedGoogle Scholar
• Calderwood SB, Swinshi LA, Karchmer AW, et al. Prosthetic valve endocarditis: analysis of factors affecting out-come of therapy. J Thorac Cardiovasc Surg 1977; 73: 416–422.
   PubMed Web of Science ®Google Scholar